Cautionary Statements NON-GAAP FINANCIAL INFORMATION Conifer • 4.1% case volume growth FY 2023 Outlook - Consolidated Adjusted EBITDA raised for the third time this year to a range of $3.365 billion to $3.465 billion 4 Note: 2023E is based on mid-point of Outlook range as of October 30, 2023. Reconciliations of these non-GAAP measures to the most comparable GAAP measures and management's reasoning for using these non-GAAP financial measures are included in our earnings press releases dated October 30, 2023, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2023 OR Form 10-Q TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada (State of Incorporation) 95-2557091 (IRS Employer Identification No.) 14201 Dallas Parkway Dallas, TX 75254 (Address of principal executive offices, including zip code) (469) 893-2200 (Registrant's ...

Tenet Healthcare Corporation (NYSE:THC) Q2 2023 Earnings Conference Call July 31, 2023 5:00 PM ET Company Participants Will McDowell - VP, IR Saum Sutaria - CEO Daniel Cancelmi - CFO Conference Call Participants Will McMahon - Barclays Jamie Perse - Goldman Sachs Pito Chickering - Deutsche Bank Justin Lake - Wolfe Research Kevin Fischbeck - Bank of America Calvin Sternick - JPMorgan Whit Mayo - Leerink Partners A.J. Rice - Credit Suisse Andrew Mok - UBS Brian Tanquilut - Jefferies Jason Cassorla - Citi Ben ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2023 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number: 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada (State of Incorporation) 95-2557091 (IRS Employ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2023 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada (State of Incorporation) 95-2557091 (IRS Employ ...

Tenet Healthcare Corporation (NYSE:THC) Q1 2023 Earnings Conference Call April 25, 2023 10:00 AM ET Company Participants Will McDowell - Vice President, Investor Relations Saum Sutaria - Chief Executive Officer Daniel Cancelmi - Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies Group LLC Pito Chickering - Deutsche Bank AG Calvin Sternick - JPMorgan Chase & Co. Kevin Fischbeck - Bank of America A.J. Rice - Credit Suisse Joshua Raskin - Nephron Research LLC Ann Hynes - Mizuho Se ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ý Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2022 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 95-2557091 (State of Incorporation) (IRS Employer Id ...

Tenet Healthcare Corporation (NYSE:THC) Q4 2022 Earnings Conference Call February 9, 2023 10:00 AM ET Company Participants Will McDowell - Vice President of Investor Relations Saum Sutaria - Chief Executive Officer Dan Cancelmi - Executive Vice President & Chief Financial Officer Conference Call Participants Kevin Fischbeck - Bank of America Jamie Perse - Goldman Sachs Justin Lake - Wolfe Research Ann Hynes - Mizuho A.J. Rice - Credit Suisse John Ransom - Raymond James Josh Raskin - Nephron Research Steven ...

| --- | --- | --- | --- | --- | --- | |-------|-------|--------------|-------|------------------|-------| | | | | | | | | | | | | | | | | th | | | | | | | | | | | | | 4 | | | | Quarter 2022 | | | | | | | | | | | | | | | | | | | | | Earnings Release | | | | | | | | | | | | | | | | | | | Presentation | | | | This presentation includes "forward looking statements." These statements relate to future events, including, but not limited to, statements regarding our liquidity, operating results, future earnings, fi ...

UNITED STATES Commission File Number 1-7293 _________________________________________ TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2022 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Nevada 9 ...